152 related articles for article (PubMed ID: 26026588)
21. Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).
Zhou T; Zhan J; Fang W; Zhao Y; Yang Y; Hou X; Zhang Z; He X; Zhang Y; Huang Y; Zhang L
BMC Cancer; 2017 Apr; 17(1):269. PubMed ID: 28410578
[TBL] [Abstract][Full Text] [Related]
22. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
Omae K; Kondo T; Tanabe K
Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
[TBL] [Abstract][Full Text] [Related]
23. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
Shen L; Li ZM; Lu S
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
[TBL] [Abstract][Full Text] [Related]
26. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.
Sieghart W; Pinter M; Hucke F; Graziadei I; Schöniger-Hekele M; Müller C; Vogel W; Trauner M; Peck-Radosavljevic M
Hepatology; 2013 Jun; 57(6):2224-34. PubMed ID: 22961713
[TBL] [Abstract][Full Text] [Related]
27. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
30. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.
Hong S; Zhou T; Fang W; Xue C; Hu Z; Qin T; Tang Y; Chen Y; Ma Y; Yang Y; Hou X; Huang Y; Zhao H; Zhao Y; Zhang L
Tumour Biol; 2015 May; 36(5):3389-97. PubMed ID: 25527156
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
32. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
34. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
Wu M; Guo J; Guo L; Zuo Q
Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma.
Nakanishi H; Araki N; Kudawara I; Kuratsu S; Matsumine A; Mano M; Naka N; Myoui A; Ueda T; Yoshikawa H
Int J Cancer; 2002 May; 99(2):167-70. PubMed ID: 11979429
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer.
Kong F; Gao F; Chen J; Zheng R; Liu H; Li X; Yang P; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(34):55765-55770. PubMed ID: 27303917
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of serum IL-17 and VEGF levels in small cell lung cancer.
Lin Q; Xue L; Tian T; Zhang B; Guo L; Lin G; Chen Z; Fan K; Gu X
Int J Biol Markers; 2015 Nov; 30(4):e359-63. PubMed ID: 26165685
[TBL] [Abstract][Full Text] [Related]
38. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM
Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778
[TBL] [Abstract][Full Text] [Related]
39. The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma.
Teishima J; Kobatake K; Kitano H; Nagamatsu H; Sadahide K; Hieda K; Shinmei S; Shoji K; Inoue S; Hayashi T; Inoue Y; Ohara S; Mita K; Matsubara A
BJU Int; 2016 Jun; 117(6B):E67-74. PubMed ID: 26305535
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between Pretreatment Serum Apolipoprotein Level and Prognosis of Small Cell Lung Cancer Patients].
Dong Y; Wang H; Shan D; Zhang L; Yu Z
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):845-851. PubMed ID: 33070513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
